Google
Click here to Top Secret Fat Loss Secret

Archive for the ‘Prostate / Prostate Cancer’ Category

Is The Increase In Orchiectomy For Prostate Cancer Patients Appropriate?

Friday, May 30th, 2008

UroToday.com - In the online version of Cancer, Gerald W. Chodak writes an editorial on the article "Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.", (Cancer. 2008;epub) from Dr. Weight and colleagues at the Cleveland Clinic.He points out how the Medicare Modernization ...

MR Imaging Accurately Determines Prostate Cancer Treatment Failure

Thursday, May 22nd, 2008

Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.The study included 27 patients who had increased levels of prostate specific antigen after being treated with high-intensity focused ultrasonic (HIFU) ablation; ...

Men’s Health Policy Center Hosts Petition To Protest Government Barrier To Prostate Cancer Medications

Thursday, April 3rd, 2008

The Men's Health Policy Center, a new resource center affiliated with the Men's Health Network (MHN), announced that they are hosting an online petition urging Congress to end a Centers for Medicare and Medicaid Services (CMS) practice that unfairly restricts prostate cancer patients' access to drug therapies. The policy, known ...

New Clues To Genetics Of Type 2 Diabetes Offered By Major International Collaboration

Tuesday, April 1st, 2008

An international collaboration of scientists from Europe and the US has identified six new genes which play a role in the development of type 2 diabetes, extending the total number of genes implicated in common forms of the disease to sixteen.The findings provide valuable new insights into the mechanisms responsible ...

A Nomogram Predicting 10-Year Life Expectancy In Candidates For Radical Prostatectomy Or Radiotherapy For Prostate Cancer

Monday, March 31st, 2008

UroToday.com - Family Physicians Could Help in Predicting Life Expectancy without Prostate Cancer. In the online version of the Journal of Clinical Oncology, Dr. Ravinder Mohan, Department of Family and Community Medicine, Eastern Virginia Medical School has published an interesting correspondence regarding the role for primary care physicians in determining ...

A One-Step Homogeneous Immunoassay For Cancer Biomarker Detection Using Gold Nanoparticle Probes Coupled With Dynamic Light Scattering

Sunday, March 23rd, 2008

UroToday.com - Millions of people around the world face the risk of cancer, which has been one of the leading causes of mortality. The early detection of cancer can significantly improve the treatment and survival rate of cancer patients. As tumors develop, the cells, tissues and organs can increase or ...

New Tool For Prostate Cancer Diagnosis

Thursday, March 20th, 2008

New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology1 support the use of PROGENSA PCA3 as a tool for diagnosing prostate cancer. The study confirms that PROGENSA PCA3, the world's first gene-based urine test to help detect prostate cancer, can provide clinicians with ...

Chronic Kidney Disease - Europe’s Silent Epidemic

Monday, March 17th, 2008

The European Kidney Health Alliance (EKHA) and World Kidney Day organisations call for European health polices to support early identification and treatment of chronic kidney disease (CKD). The meeting, held in the European Parliament, marks the occasion of World Kidney Day, which this year will be on 13th March. An ...

GTx’s Toremifene Citrate 80 Mg Meets Primary And Key Endpoints In Phase III Trial In Advanced Prostate Cancer Patients On Androgen Deprivation Therapy

Monday, March 17th, 2008

GTx, Inc. (NASDAQ:GTXI) announced Phase III clinical data for toremifene citrate 80 mg, the Company's investigational therapy for the treatment of multiple side effects of androgen deprivation therapy (ADT) for advanced prostate cancer. Results show that toremifene citrate 80 mg reduced vertebral fractures and met other key endpoints, including bone ...

Nymox’s NX-1207 Offers A New And Attractive Approach To The Treatment Of Benign Prostatic Hyperplasia

Monday, March 17th, 2008

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) provided an outline of the outstanding potential the Company's proprietary drug, NX-1207, has for the treatment of the common condition of enlarged prostate or benign prostatic hyperplasia (BPH). In clinical trials, NX-1207 treatment for BPH has shown a superior safety and efficacy profile compared to ...

Cougar Biotechnology Presents Positive CB7630 Phase I And Phase II Data At ASCO 2008 Genitourinary Cancers Symposium

Monday, March 17th, 2008

Cougar Biotechnology, Inc. (NASDAQ:CGRB) announced that results from ongoing Phase I and Phase II clinical trials of Cougar's investigational drug, CB7630 (abiraterone acetate), were presented at the ASCO Genitourinary Cancers Symposium that is currently taking place in San Francisco, California. The data was presented today in both an oral presentation ...

Beyond The Abstract: Anatomic Excision Of Anterior Prostatic Fat At Radical Prostatectomy: Implications For Pathologic Upstaging

Saturday, March 8th, 2008

UroToday.com - It is very exciting when you take an operation that has been around since 1905 and uncover new information that was literally right in front of us all along. We found several interesting things. First, we found lymph nodes in the anterior prostatic fat (APF) in about 15% ...

After Radical Retropubic Prostatectomy ‘Insignificant’ Prostate Cancer Has A Risk Of Progression Similar To Low Risk ‘Significant’ Cancer

Saturday, March 8th, 2008

UroToday.com- In a report in the January, 2008 issue of the British Journal of Urology International, Dr. Sengupta and associates from the Mayo Clinic assess the risk of progression and death among patients with pathologically insignificant tumors after radical prostatectomy (RP) for prostate cancer (CaP). Insignificant CaP was defined ...

Effects Of Pathologic Stage On The Learning Curve For Radical Prostatectomy

Saturday, March 8th, 2008

UroToday.com - In the online version of European Urology, a group from Memorial-Sloan Kettering Cancer Center, the Cleveland Clinic and Wayne State investigate how pathologic stage would affect the learning curve in radical prostatectomy (RP) for prostate cancer (CaP). Andrew Vickers is the lead author.There is existing evidence that ...

Power-Packed Soy Breakfast Cereal Developed By U Of I Researcher

Friday, March 7th, 2008

Breakfast of champions? That would be a soy protein-packed, low-fat, high-fiber cereal that meets the requirements for three different FDA health claims and leaves you feeling full so you won't be tempted to eat again until lunch.University of Illinois scientist Soo-Yeun Lee has cooked up a "recipe" for just such ...